03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Cancer
Aparna Kamat: no photograph is held, so the academic plate is shown instead.
Academic
Aparna Kamat
Director of the Division of Gynaecologic Oncology, Houston Methodist Hospital, Texas
6
0
0
0
0
0
June 2026July 2026Aug 2026Sept 2026Oct 2026Nov 2026to date
6
press citations on 2 topics since 7 Jun 2026 · last quoted 15 Jun 2026
04 The signal · where Aparna Kamat sits on cancer
Ranked 20= of 100 voices quoted in the press on cancer, level with 14 others on 5 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Prof Peter JohnsonClinicianNational Clinical Director for Cancer, NHS England53 - 2
Michelle MitchellSector leaderChief Executive, Cancer Research UK18 - 3
Professor Victoria Tzortziou BrownClinicianChair of Council, Royal College of General Practitioners (RCGP)17 - 16=Dr Sowmiya MoorthieAcademicSenior Strategic Evidence Manager, Cancer Research UK6
- 16=
Chiara De BiaseSector leaderInterim Fundraising and Health Strategy Director, Prostate Cancer UK6 - 20=Aparna KamatAcademicDirector of the Division of Gynaecologic Oncology, Houston Methodist Hospital, Texas5
- 20=Professor Montse Garcia-ClosasAcademicGroup Leader in Integrative Cancer Epidemiology at the ICR5
- 20=Andrea BilleClinicianProfessor, consultant thoracic surgeon5
Showing the leaders and the ranks around 20=, of 100 voices · See every voice on the topic →
05 On the record · press
What Aparna Kamat has said
By outlet · linked articles
- mirror.co.uk2
- dailyrecord.co.uk1
- express.co.uk1
- independent.co.uk1
- scotsman.com1
Where Aparna Kamat has been quoted
- 01NHS pharmacist warns summer heat could make popular drug less effectiveexpress.co.uk · 15 Jun 2026
- 02Weight loss jabs should be investigated as 'cancer prevention agents' - expertsscotsman.com · 8 Jun 2026
- 03Weight-loss jabs could slash cancer risk 41 per cent, experts saymirror.co.uk · 8 Jun 2026
- 04Weight-loss injections could cut cancer risk by 41pc, finds studydailyrecord.co.uk · 8 Jun 2026
- 05Weight loss jabs 'should be probed as cancer prevention agents' after US studymirror.co.uk · 7 Jun 2026
- 06Experts call for weight loss jabs to be investigated for cancer preventionindependent.co.uk · 7 Jun 2026
Verbatim
“Our study found that over an average follow-up of two years, GLP-1 RA use was associated with a significantly lower incidence of cancers directly fuelled by excess body weight”
“Our findings do not prove causation, and cancer risk reduction should not yet be a standalone reason to prescribe GLP-1 RAs.”
“Our findings do not prove causation, and cancer risk reduction should not yet be a standalone reason to prescribe GLP-1 RAs. However, for obese, non-diabetic patients who are already candidates for these medications, our data provide an additional and potentially important reason to have that conversation.”
“Our findings do not prove causation, and cancer risk reduction should not yet be a standalone reason to prescribe GLP-1 RAs.”
“Our findings do not prove causation, and cancer risk reduction should not yet be a standalone reason to prescribe GLP-1 RAs.”
“Our findings do not prove causation, and cancer risk reduction should not yet be a standalone reason to prescribe GLP-1 RAs.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- I'm a Top Oncologist: 5 Women's Health Symptoms I'd Never Ignoremarieclaire.co.uk
- Somerset residents urged to look out for mouth cancer symptomsburnhamandhighbridgeweeklynews.co.uk
- Two-minute mouth checks could help save lives in Somersetchardandilminsternews.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.